{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259332257", "close" : "1259344857", "flags" : {"ce" : "The Thanksgiving Weekend"}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
ap

Rigel Pharma to sell 6M shares in public offering

Rigel Pharmaceuticals to sell 6 million shares in public offering

  • On 5:51 pm EDT, Wednesday September 16, 2009

SOUTH SAN FRANCISCO, Calif. (AP) -- Rigel Pharmaceuticals Inc. said Wednesday it plans to offer 6 million shares of the company in a public offering.

The development-stage biotechnology company said it expects to grant underwriters an option to buy an additional 900,000 shares to cover over-allotments.

Rigel did not indicate how it would use net proceeds from the sale.

Credit Suisse Securities (USA) LLC will be acting as the sole book-runner for the offering, with Oppenheimer & Co. Inc. and Thomas Weisel Partners LLC acting as co-managers.

Shares of Rigel fell 44 cents, or 5.7 percent, to $7.22 in after-hours trading following the announcement of the offering. During the regular session, the stock climbed 5 cents to close at $7.66.

Related Headlines

Top Stories

Related Message Boards

Sponsored Links

Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.